FOR IMMEDIATE RELEASE

Lingraphica Welcomes Jaleel Shujath as Director of Sales and Marketing

Princeton, NJ. – February 21, 2022 - Lingrapghica, Inc., one of the nation’s leading medical devices companies serving persons affected by aphasia, announced today it has hired Jaleel Shujath to the position of Director, Sales and Marketing.

In this role, Mr. Shujath will lead the effort to increase awareness of Lingraphica’s innovative augmentative and alternative communication (AAC) devices among stroke victims and speech language pathologists. He brings several years of experience marketing technology solutions to life sciences researchers, while at Cellomics, GE Healthcare, and PBL InterferonSource.

Located at Lingraphica’s Princeton, New Jersey office, he reports to the CEO Andrew Gomory. “Jaleel’s extensive marketing experience international background, impressive track record at PBL and GE, and his enthusiasm for business challenges and team-based success, will serve him well at Lingraphica,” said Mr. Gomory.

Mr. Shujath is a member of the American Marketing Association. He earned a Bachelor of Science in Biology from Tufts University and an MBA in Marketing from the University of New Haven School of Business
.
About Lingraphica, Inc.
Lingraphica-The Aphasia Company™ is the leading provider of speech-generating devices for people whose ability to speak or understand words has been impaired by a stroke or brain injury. With the Lingraphica they can communicate with picture icons that speak words and phrases in a natural human voice, or they can practice speech using videos and language exercises. The Lingraphica is Medicare reimbursable. It is available for a no-obligation trial. For more information call toll-free 1-888-APHASIA (1-888-274-2742) or visit www.aphasia.com.
.